Sulfa Resistance and Dihydropteroate Synthase Mutants in Recurrent Pneumocystis carinii Pneumonia
2003

Sulfa Resistance in Pneumocystis carinii Pneumonia

Sample size: 13 publication Evidence: moderate

Author Information

Author(s): Nahimana Aimable, Rabodonirina Meja, Helweg-Larsen Jannik, Meneau Isabelle, Francioli Patrick, Bille Jacques, Hauser Philippe M.

Primary Institution: Centre Hospitalier Universitaire Vaudois, Lausanne, Switzerland

Hypothesis

Can mutations in the dihydropteroate synthase (DHPS) gene of Pneumocystis carinii be selected by sulfa or sulfone drug pressure in AIDS patients with recurrent pneumonia?

Conclusion

The study suggests that DHPS mutations in Pneumocystis carinii may be selected in patients under the pressure of sulfa or sulfone drugs, potentially leading to drug resistance.

Supporting Evidence

  • The study found that DHPS mutations are associated with failure of sulfa or sulfone prophylaxis.
  • Patients with recurrent pneumonia showed a change in DHPS genotype between episodes.
  • The majority of second episodes caused by reactivation had mutant DHPS strains.

Takeaway

Some sick people can get the same lung infection more than once, and the medicine they take can make the germs stronger and harder to treat.

Methodology

The study analyzed bronchoalveolar lavage specimens from patients with recurrent Pneumocystis carinii pneumonia to investigate DHPS mutations.

Potential Biases

Potential bias in patient selection and treatment regimens may affect the results.

Limitations

The study's findings may not be generalizable due to the small sample size and specific patient demographics.

Participant Demographics

All participants were AIDS patients, mostly men, with a median age of 35 years.

Statistical Information

P-Value

p<0.02

Statistical Significance

p<0.02

Digital Object Identifier (DOI)

10.3201/eid0907.020753

Want to read the original?

Access the complete publication on the publisher's website

View Original Publication